Snowboarding Safety

Business

CME Group Raises Metals Trading Margins Amid Historic Volatility, Records Surge in Volume

CME Group has increased margin requirements for precious metals futures and options following extreme price swings, as daily trading volumes hit record highs. The exchange is also introducing new silver products and enforcing compliance measures, highlighting its dual role as a market facilitator and risk manager during turbulent times.

Feb 2, 2026

Business

Norfolk Southern Unveils Major East Coast Rail Corridor, Aiming to Unclog Freight Bottlenecks

Norfolk Southern has inaugurated its new 'East Edge' double-stack corridor, a decades-in-the-making infrastructure project linking Chicago to New England. The move is set to bolster intermodal capacity in the Northeast and could sharpen the railroad's competitive edge and investor appeal.

Feb 2, 2026

Business

Income Shift: Three Vanguard Dividend ETFs Gaining Favor as Retirement Portfolios Rotate

As market leadership broadens beyond tech, income-focused investors are turning to high-yield dividend ETFs. Vanguard's suite offers diversified, cost-effective options for building retirement income streams in a changing landscape.

Feb 2, 2026

Business

Quince Therapeutics Plummets After Late-Stage Trial of A-T Therapy Fails to Hit Targets

Quince Therapeutics' lead candidate, eDSP, has failed to meet primary and secondary endpoints in its pivotal Phase III NEAT trial for the rare neurological disorder Ataxia-Telangiectasia (A-T), triggering a catastrophic drop in the company's share price.

Feb 2, 2026

US

Government Shutdown Looms, Grammys Spotlight Immigration as Protests Sweep Nation

A partial government shutdown triggers furloughs, the Grammys become a platform for political statements, and nationwide protests over immigration policy unfold amid a severe winter storm's aftermath.

Feb 2, 2026

FDA Rejects Aquestive's Oral Anaphylaxis Treatment, Leaving Patients Awaiting Epinephrine Alternative

The U.S. Food and Drug Administration has issued a complete response letter for Aquestive Therapeutics' oral film drug designed to treat severe allergic reactions, the company announced Monday, delaying a potential new option for millions at risk.

Feb 2, 2026

Business

Visa and Mastercard Post Strong Quarterly Gains, Fueling Debate Over Long-Term Value

The payments giants Visa and Mastercard reported robust revenue and earnings growth for their latest quarters, though their premium valuations continue to spark investor debate on which offers the superior long-term opportunity.

Feb 2, 2026

Missouri's Legal Cannabis Industry Sues Smoke Shops Over 'Hemp' Loophole

A coalition of licensed marijuana companies in Missouri has launched a wave of lawsuits against dozens of smoke shops, alleging they are exploiting a legal gray area to sell intoxicating THCA hemp flower, undermining the state's regulated market and creating unfair competition.

Feb 2, 2026

Business

Eli Lilly Bets Nearly $2 Billion on Repertoire Immune Medicines to Pioneer Next-Generation Autoimmune Therapies

Pharmaceutical giant Eli Lilly enters a strategic collaboration potentially worth up to $1.93 billion with biotech firm Repertoire Immune Medicines, aiming to develop precision treatments for autoimmune diseases that move beyond broad immunosuppression.

Feb 2, 2026

Business

Precious Metals Rout Rattles Global Markets as Investors Seek Shelter

A sharp sell-off in gold and silver, alongside falling oil prices, has sparked volatility across global markets at the start of a week packed with major earnings and central bank decisions.

Feb 2, 2026

Business

Market Watch: Three Undervalued Stocks Trading at Steep Discounts to Intrinsic Value

Amid a choppy market landscape in early 2026, value investors are scanning for opportunities. We analyze three companies—Viavi Solutions, Kontoor Brands, and Robert Half—whose current share prices appear significantly disconnected from their estimated intrinsic worth based on cash flow projections.

Feb 2, 2026

World

A Nation Preparing for the Inevitable: Zimbabwe's Funeral Insurance Boom Overshadows Healthcare Crisis

In Zimbabwe, where formal employment is scarce and medical costs are prohibitive, a stark financial choice is being made: affordable funeral policies are vastly outpacing health insurance, reflecting a cultural prioritization of dignified burials over accessible healthcare.

Feb 2, 2026

Business

Trump's Fed Pick Sparks Metals Meltdown: Gold, Silver Tumble as Hawkish Outlook Strengthens Dollar

Precious metals extended their sharp decline following President Trump's nomination for the next Federal Reserve chair, a move markets interpret as locking in higher interest rates and boosting the U.S. dollar's appeal.

Feb 2, 2026

Business

Waymo Eyes $16 Billion Funding at Near $110 Billion Valuation, Fueling Autonomous Vehicle Race

Alphabet's self-driving unit Waymo is in advanced talks to secure a massive $16 billion funding round, potentially valuing the company at around $110 billion, as competition in the robotaxi market intensifies.

Feb 2, 2026

Business

Analysts See Hidden Value in CuriosityStream: Stock Could Be Undervalued by Over 20%

A new financial analysis suggests shares of the documentary-focused streaming service CuriosityStream may be trading significantly below their estimated intrinsic value, presenting a potential opportunity for investors.

Feb 2, 2026

Business

Insiders Bet Big on 908 Devices: A Vote of Confidence in the Future?

A wave of insider buying at 908 Devices Inc. has caught the market's attention, signaling potential optimism among those who know the company best. While not a guaranteed predictor, such coordinated activity often precedes significant corporate developments.

Feb 2, 2026

Business

Cogent Biosciences Gains Key FDA Designations for Bezuclastinib, Spotlighting GIST Treatment Potential

Cogent Biosciences secures FDA Breakthrough Therapy Designation and enters the Real-Time Oncology Review program for its lead drug candidate bezuclastinib in gastrointestinal stromal tumors (GIST), marking significant regulatory momentum for the biotech firm.

Feb 2, 2026

Business

Truist Financial Shares Trade at a Discount: Is the Market Overlooking Its Earnings Potential?

A deep dive into Truist Financial's valuation suggests its current share price may not fully reflect its underlying earnings power and book value, presenting a potential opportunity for investors.

Feb 2, 2026

Business

Analysts See Deep Value in Eos Energy Enterprises as Stock Trades at Steep Discount

A new valuation model suggests Eos Energy Enterprises' stock could be significantly undervalued, presenting a potential opportunity for investors amid a shifting energy policy landscape.

Feb 2, 2026

Business

Investors Flee Crypto in $1.7 Billion Weekly Exodus, Seek Refuge in Tokenized Metals

Digital asset funds have recorded a second consecutive week of massive outflows, totaling $1.7 billion, as hawkish Fed signals and geopolitical tensions trigger a defensive shift. While Bitcoin and Ethereum led the retreat, tokenized precious metals emerged as a rare destination for new capital.

Feb 2, 2026